title: Bleomycin-induced flagellate hyperpigmentation.
abstract: Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy.
authors.affiliation: Department of Dermatology and Venereology, Hospital de Braga, Braga, Portugal. cristinapresende@gmail.com
authors.forename: Cristina
authors.initials: C
authors.lastname: Resende
authors.forename: Catarina
authors.initials: C
authors.lastname: Araújo
authors.forename: Joana
authors.initials: J
authors.lastname: Gomes
authors.forename: Celeste
authors.initials: C
authors.lastname: Brito
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects*; D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin